Dr. Shi of EdgeTech Law: Despite Mayo Clinic v. Prometheus “Setback,” Opportunities in Life Sciences Remain
OneMedPlace is pleased to announce a special interview series exploring current issues facing the diagnostics sector and life sciences.
Month: April 2012
Biovest CEO and Sr. Vice President Discuss Global Marketing of BiovaxID
Biovest International, Inc. (OTCQB: BVTI) announced that Biovest is seeking marketing approval in Canada for BiovaxID®, its personalized cancer vaccine for the treatment of follicular non-Hodgkin’s lymphoma.
NeuroMetrix Files 510(k) for SENSUS(TM) Pain Therapy Device
NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes has filed a 510(k), with the FDA for its SENSUS Pain Therapy device.
Complete Genomics Well Positioned to Move from Research to Clinical in Genome Sequencing
OneMedRadio recently conducted an interview with Dr. Clifford A. Reid, the company’s President and Chief Executive Officer.
Epigenomics Enrolls First Participant in its FIT Comparative Study with Epi proColon®
OneMedRadio interviewed Thomas Taapken, CFO of Epigenomics, a Berlin based molecular diagnostics company for the early detection of cancer.
AVI Biopharma’s Chief Science Officer To Resign
Drug developer AVI Biopharma Inc. said Thursday that Chief Scientific Officer Peter Linsley will resign from the company.
PTSD Special Report, Part II: Promising Treatments and Emerging Opportunities
This is Part II of our special report on PTSD, a survey of the rising causes for concern and potential treatments to combat it.
Advaxis Receives Best Therapeutic Vaccine Award
The 5th Annual Vaccine Industry Excellence Awards has named Advaxis as the Best Therapeutic Vaccine for the company’s ADVX-HPV construct.
PTSD Special Report: Part I, How to Curb a Potential Epidemic
In response to a recent press release from TONIX Pharmaceuticals, a leading company in the exploration of alternative PTSD treatment, we are issuing a 2-part special report looking at recent developments
March/April 2012
The OneMedResearch March/April 2012 Issue continues the discussion of 10 small companies with intriguing technology in an emerging market. This issue focuses its efforts on supplementing previous initiation […]